Startseite Asymmetric dimethylarginine (ADMA) and L-arginine levels in children with glycogen storage disease type I
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Asymmetric dimethylarginine (ADMA) and L-arginine levels in children with glycogen storage disease type I

  • Çiğdem Seher Kasapkara EMAIL logo , Leyla Tümer , Gursel Biberoglu , Ahmet Kasapkara und Alev Hasanoğlu
Veröffentlicht/Copyright: 15. Februar 2013

Abstract

Patients with glycogen storage disease type I (GSD-I) often have marked hyperlipidemia with abnormal lipoprotein profiles. This metabolic abnormality improves, but is not fully corrected, with dietary therapy; therefore, these patients may be at high risk for the development of atherosclerosis. A recently discussed cardiovascular risk factor, asymmetric dimethylarginine (ADMA), a naturally occuring product of asymmetric methylation of proteins, is an endogenous inhibitor of endothelial nitric oxide synthase. ADMA causes endothelial dysfunction, vasoconstriction, blood pressure elevation, atherosclerosis, and kidney disease progression. A high prevalence of elevated plasma ADMA levels is observed in adults with hypercholesterolemia, hypertension, chronic kidney disease, diabetes mellitus, peripheral arterial disease, coronary artery disease, preeclampsia, heart failure, liver disease, stroke, and many other clinical disorders. Therefore, we aimed to evaluate the endothelial function in patients with GSD-I by using ADMA levels. High-performance liquid chromatography – based method was used for measuring ADMA and L-arginine levels in plasma. The ADMA level was similar between children with GSD-I and the age-matched healthy control group (0.9±0.28 vs. 1.1±0.45 μmol/L; p=0.18). The L-arginine plasma levels in patients with GSD-I were found to be 55.7±41.3 and 91.6±50.2 μmol/L in healthy controls. The preservation of normal endothelial function may result from diminished platelet aggregation, increased levels of apolipoprotein E, decreased susceptibility of low-density lipoprotein to oxidation (possibly related to the altered lipoprotein fatty acid profile in GSD-I), and increased antioxidative defenses in plasma protecting against lipid peroxidation.


Corresponding author: Çiğdem Seher Kasapkara, Pediatric Metabolic Unit, Gazi University Medical School, Besevler, Ankara 06500, Turkey

References

1. Froissart R, Piraud M, Boudjemline AM, Vianey-Saban C, Petit F, et al. Glucose-6-phosphatase deficiency (review). Orphanet J Rare Dis 2011;6:27.Suche in Google Scholar

2. Taki M, Inagaki M, Tomita Y, Meguro T, Yamada K. Abnormal platelet adhesion to subendothelium and thrombus formation in glycogen storage disease, type I (author’s translation). Rinsho Ketsueki 1981;22:1875–9.Suche in Google Scholar

3. den Hollander NC, Mulder DJ, Graaff R, Thorpe SR, Baynes JW, et al. Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia. J Inherit Metab Dis 2007;30:916–23.Suche in Google Scholar

4. Lee PJ, Leonard JV. The hepatic glycogen storage diseases – problems beyond childhood (review). J Inherit Metab Dis 1995;18:462–72.Suche in Google Scholar

5. Eliana F, Suwondo P, Makmun LH, Harbuwono DS. ADMA as a marker of endothelial dysfunction in prediabetic women. Acta Med Indones 2011;43:92–8.Suche in Google Scholar

6. Hasanoğlu A, Okur I, Oren AC, Biberoğlu G, Oktar S, et al. The levels of asymmetric dimethylarginine, homocysteine and carotid intima-media thickness in hypercholesterolemic children. Turk J Pediatr 2011;53:522–7.Suche in Google Scholar

7. Sibal L, Agarwal SC, Home PD, Boger RH. The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev 2010;6:82–90.Suche in Google Scholar

8. Kaida Y, Ueda S, Yamagishi S, Nakayama Y, Ando R, et al. Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome. Life Sci 2012;91:301–5.Suche in Google Scholar

9. PokrovskiĬ MV, Pokrovskaia TG, Gureev VV, Barsuk AA, Proskuriakova EV, et al. Correction of endothelial dysfunction by L-arginine under experimental pre-eclampsia conditions. Eksp Klin Farmakol 2012;75:14–6.Suche in Google Scholar

10. Mohan S, Fung HL. Mechanism of cellular oxidation stress induced by asymmetric dimethylarginine. Int J Mol Sci 2012;13:7521–31.Suche in Google Scholar

11. Trioche P, Francoual J, Capel L, Odièvre M, Lindenbaum A, et al. Apolipoprotein E polymorphism and serum concentrations in patients with glycogen storage disease type Ia. J Inherit Metab Dis 2000;23:107–12.Suche in Google Scholar

12. Lee PJ, Celermajer DS, Robinson J, McCarthy SN, Betteridge DJ, et al. Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis 1994;110:95–100.Suche in Google Scholar

13. Becker BF, Reinholz N, Ozçelik T, Leipert B, Gerlach E. Uric acid as radical scavenger and antioxidant in the heart. Pflugers Arch 1989;415:127–35.Suche in Google Scholar

14. Bernier AV, Correia CE, Haller MJ, Theriaque DW, Shuster JJ, et al. Vascular dysfunction in glycogen storage disease type I. J Pediatr 2009;154:588–91.Suche in Google Scholar

Received: 2012-9-28
Accepted: 2012-12-16
Published Online: 2013-02-15
Published in Print: 2013-05-01

©2013 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorial
  4. Success has many fathers, failure is orphan
  5. Review Article
  6. Normosmic idiopathic hypogonadotropic hypogonadism: update on the genetic background and future challenges
  7. Original Articles
  8. Temporary brittle bone disease: association with intracranial bleeding
  9. Asymmetric dimethylarginine (ADMA) and L-arginine levels in children with glycogen storage disease type I
  10. Application of liquid chromatography-tandem mass spectrometry in the diagnosis and follow-up of maple syrup urine disease in a Chinese population
  11. The role of uncoupling protein 2 and 3 genes polymorphism and energy expenditure in obese Indonesian children
  12. Thyroid dysfunctions of prematurity and their impacts on neurodevelopmental outcome1)
  13. Frequency of the E23K polymorphism of the KCNJ11 gene in children born small for gestational age and its influence on auxological and metabolic parameters in the prepubertal period
  14. Reference intervals for serum thyroid hormones in preterm hospitalized infants1)
  15. The clinical and biochemical presentation of vitamin D deficiency and insufficiency in children and adolescents
  16. A risk score for identifying overweight adolescents with dysglycemia in primary care settings1)
  17. Thyroid function and morphology in overweight and obese children and adolescents in a Chinese population
  18. Propionic acidaemia: demographic characteristics and complicationsa
  19. Negative correlation between serum IL-6 level and cardiorespiratory fitness in 10- to 11-year-old boys with increased BMI
  20. Penile length and genital anomalies in Egyptian male newborns: epidemiology and influence of endocrine disruptors
  21. Efficacy of vitamin D loading doses on serum 25-hydroxy vitamin D levels in school going adolescents: an open label non-randomized prospective trial
  22. Characteristics of infants admitted with hypoglycemia to a neonatal unit
  23. Increasing thyroid-stimulating hormone is associated with impaired glucose metabolism in euthyroid obese children and adolescents
  24. The role of FTO genotype on eating behavior in obese Sardinian children and adolescents
  25. Prevalence of multiple forms of autoimmunity in Egyptian patients with Turner syndrome: relation to karyotype
  26. A novel DAX-1 mutation presented with precocious puberty and hypogonadotropic hypogonadism in different members of a large pedigree
  27. Patient Reports
  28. Pseudohypoparathyroidism type Ia: a novel GNAS mutation in a Brazilian boy presenting with an early primary hypothyroidism
  29. Diabetic ketoacidosis with cerebral hemorrhage and alpha coma in an adolescent female
  30. A novel mutation in thyrotropin (thyroid-stimulating hormone) gene in congenital hypothyroidism
  31. Citric acid as the last therapeutic approach in an acute life-threatening metabolic decompensation of propionic acidaemia
  32. A case of autosomal dominant osteopetrosis type II with a novel TCIRG1 gene mutation
  33. The interpretation of color – an endocrine cause of skin discoloration mimicking cyanosis
  34. Novel heterozygous thyrotropin receptor mutation presenting with neonatal hyperthyrotropinaemia, mild thyroid hypoplasia and absent uptake on radioisotope scan
  35. Turner Syndrome and apparent absent uterus: a case report and review of the literature
  36. 10.1515/jpem-2012-0133
  37. Vaginal bleeding in a 4-month-old preterm girl: extreme minipuberty mimicking central precocious puberty
  38. A rare case of isolated Cushing syndrome in a 3-month-old boy
  39. Letters to the Editors
  40. Gynecomastia in puberty is usually asymptomatic and regresses spontaneously
  41. Is endometriosis ultimately the end result of the interplay between interferon-γ (IFN-γ) and the HOXA10 gene network?
  42. Does treatment with L-selenomethionine reduce thyroid volume in euthyroid children with autoimmune thyroiditis?
  43. Meetings
  44. Meetings Calendar
Heruntergeladen am 3.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2012-0306/html
Button zum nach oben scrollen